Lv45
462 积分 2023-03-18 加入
Immunogenic Cell Death in Cancer Therapy
3天前
已完结
Non-small-cell lung cancer
3天前
已完结
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
13天前
已完结
The association between STK11/LKB1 and/or KEAP1 mutations and response to PD-1/PD-L1 inhibitors in patients with advanced non-small cell lung cancer (NSCLC)
13天前
已关闭
The piperazine scaffold for novel drug discovery efforts: the evidence to date
15天前
已完结
Design, Synthesis, and Biological Evaluation of 2,4-Imidazolinedione Derivatives as HDAC6 Isoform-Selective Inhibitors
16天前
已完结
Efficient Synthesis and Bioevaluation of Novel Dual Tubulin/Histone Deacetylase 3 Inhibitors as Potential Anticancer Agents
16天前
已完结
Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer
16天前
已完结
Tubulin inhibitors in non-small cell lung cancer: looking back and forward
17天前
已完结
Dual molecule targeting HDAC6 leads to intratumoral CD4+ cytotoxic lymphocytes recruitment through MHC-II upregulation on lung cancer cells
17天前
已完结
皖公网安备34019202002308
